Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications
Phase I trial of histone deacetylase inhibitor panobinostat in addition to glucocorticoids for primary therapy of acute graft-versus-host disease.
Journal: Bone marrow transplantation
Published: November 16, 2017
Hypoalbuminemia at Day +90 Is Associated with Inferior Nonrelapse Mortality and Overall Survival in Allogeneic Hematopoietic Cell Transplantation Recipients: A Confirmatory Study.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: August 08, 2017
TP53 and IDH2 Somatic Mutations Are Associated With Inferior Overall Survival After Allogeneic Hematopoietic Cell Transplantation for Myelodysplastic Syndrome.
Journal: Clinical lymphoma, myeloma & leukemia
Published: March 24, 2017
IL-2 promotes early Treg reconstitution after allogeneic hematopoietic cell transplantation.
Journal: Haematologica
Published: July 19, 2016
Coping strategies modify risk of depression associated with hematopoietic cell transplant symptomatology.
Journal: Journal of health psychology
Published: April 24, 2016
Evaluation of the psychometric properties of the PROMIS Cancer Fatigue Short Form with cancer patients.
Journal: Journal of psychosomatic research
Published: August 11, 2015
Prolonged sirolimus administration after allogeneic hematopoietic cell transplantation is associated with decreased risk for moderate-severe chronic graft-versus-host disease.
Journal: Haematologica
Published: January 07, 2015
Ofatumumab in combination with glucocorticoids for primary therapy of chronic graft-versus-host disease: phase I trial results.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: January 07, 2015
Pretransplantation 5-azacitidine in high-risk myelodysplastic syndrome.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: December 27, 2013
Phase II study of CD4+-guided pentostatin lymphodepletion and pharmacokinetically targeted busulfan as conditioning for hematopoietic cell allografting.
Journal: Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation
Published: February 05, 2013
Outcome of azacitidine treatment in patients with therapy-related myeloid neoplasms with assessment of prognostic risk stratification models.
Journal: Leukemia research
Published: August 24, 2012
Last Updated: 09/26/2026